Palliative Surgery or Metallic Stent Positioning for Advanced Gastric Cancer: Differences in QOL.
gastric cancer
stent positioning
stomach-partitioning gastrojejunostomy
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
28 Apr 2021
28 Apr 2021
Historique:
received:
11
02
2021
revised:
12
04
2021
accepted:
27
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Twenty percent of the patients affected with stage IV antropyloric stomach cancer are hospitalized with a gastric outlet obstruction syndrome (GOOS) requiring its resolution to improve the quality of life (QoL). We present our preliminary short- and mid-term results regarding the influence of endoscopic placement of self-expandable metal stent (SEMS) or open stomach-partitioning gastrojejunostomy in QoL. In this prospective randomized longitudinal cohort trial, we randomly assigned 27 patients affected with stage IV antropyloric stomach cancer into two groups: Group 1 (13 patients) who underwent SEMS positioning and Group 2 (14 patients) in whom open stomach-partitioning gastrojejunostomy was performed. The Karnofsky performance scale and QoL assessment using the EQ-5D-5L™ questionnaire was administered before treatment and thereafter at 1, 3, and 6 months. Results Early QoL of patients affected with stage IV antropyloric cancer and symptoms of GOOS is significantly better in patients treated with SEMS positioning but at 6-month the QoL significantly decrease in this group of patients. We explained the reasons of this fluctuation with the higher risk of re-hospital admission in the SEMS group.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Twenty percent of the patients affected with stage IV antropyloric stomach cancer are hospitalized with a gastric outlet obstruction syndrome (GOOS) requiring its resolution to improve the quality of life (QoL). We present our preliminary short- and mid-term results regarding the influence of endoscopic placement of self-expandable metal stent (SEMS) or open stomach-partitioning gastrojejunostomy in QoL.
MATERIALS AND METHODS
METHODS
In this prospective randomized longitudinal cohort trial, we randomly assigned 27 patients affected with stage IV antropyloric stomach cancer into two groups: Group 1 (13 patients) who underwent SEMS positioning and Group 2 (14 patients) in whom open stomach-partitioning gastrojejunostomy was performed. The Karnofsky performance scale and QoL assessment using the EQ-5D-5L™ questionnaire was administered before treatment and thereafter at 1, 3, and 6 months. Results
CONCLUSIONS
CONCLUSIONS
Early QoL of patients affected with stage IV antropyloric cancer and symptoms of GOOS is significantly better in patients treated with SEMS positioning but at 6-month the QoL significantly decrease in this group of patients. We explained the reasons of this fluctuation with the higher risk of re-hospital admission in the SEMS group.
Identifiants
pubmed: 33925171
pii: medicina57050428
doi: 10.3390/medicina57050428
pmc: PMC8146574
pii:
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Endoscopy. 1998 Aug;30(6):553-8
pubmed: 9746165
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Ann R Coll Surg Engl. 2016 May;98(5):340-1
pubmed: 27087329
Endoscopy. 2003 Jun;35(6):483-9
pubmed: 12783345
Surg Endosc. 2017 Oct;31(10):4165-4173
pubmed: 28281116
Colorectal Dis. 2015 Apr;17(4):356-60
pubmed: 25524247
Surg Endosc. 2010 Feb;24(2):290-7
pubmed: 19551436
Gastrointest Endosc. 2007 Dec;66(6):1206-10
pubmed: 18028923
Surg Endosc. 2013 Mar;27(3):1045-8
pubmed: 23052503
Arch Surg. 1997 Feb;132(2):184-7
pubmed: 9041924
Endoscopy. 2013 Jun;45(6):493-5
pubmed: 23733731
Anticancer Res. 2004 Jan-Feb;24(1):269-71
pubmed: 15015607
Am J Surg. 2013 Aug;206(2):210-7
pubmed: 23735668
Surg Endosc. 2016 Feb;30(2):797-801
pubmed: 26017913
In Vivo. 2019 Nov-Dec;33(6):2065-2070
pubmed: 31662539
Am J Surg. 2014 Sep;208(3):465-9
pubmed: 24560186
Langenbecks Arch Surg. 2016 Sep;401(6):777-85
pubmed: 27339200
ANZ J Surg. 2016 Jun;86(6):464-8
pubmed: 25288128
Ann R Coll Surg Engl. 2014 Oct;96(7):558
pubmed: 25245752
J Gastrointest Surg. 2016 Nov;20(11):1802-1806
pubmed: 27510331
Value Health. 2013 Jul-Aug;16(5):814-22
pubmed: 23947975
J Gastrointest Surg. 2015 Jun;19(6):1029-35
pubmed: 25731827
Gastrointest Endosc. 2007 May;65(6):782-7
pubmed: 17324410
Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):323
pubmed: 24518484
Rapid Commun Mass Spectrom. 2007;21(11):1776-82
pubmed: 17486673
Surg Laparosc Endosc Percutan Tech. 2019 Jun;29(3):169-172
pubmed: 30855401
Adv Ther. 2010 Oct;27(10):691-703
pubmed: 20737260
Gut Liver. 2017 Jul 15;11(4):481-488
pubmed: 28208004
Crit Care. 2002 Feb;6(1):66-71
pubmed: 11940268
J Clin Oncol. 1984 Mar;2(3):187-93
pubmed: 6699671